Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Soft Cell Biological Research (SCBR) is a biotechnology company based in St. George, Utah, specializing in the study of the circulating microbiome and L-form (cell wall deficient) bacteria. Founded in 2014 by J. Brent Hunt, the company has developed a proprietary, patent-pending protocol to culture and sequence these "dark bacteria" which are often linked to chronic and autoimmune diseases. Through its subsidiary, Soft Cell Labs, the company provides high-complexity molecular diagnostic testing, including pharmacogenomics (PGx) and infectious disease panels. SCBR's research aims to bridge the gap between hidden bacterial infections and conditions such as fibromyalgia, chronic fatigue syndrome, and recurrent urinary tract infections. The company operates a state-of-the-art 13,000-square-foot laboratory and maintains a strong partnership with Utah Tech University.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Soft Cell Biological Research.